What are the benefits and risks of a transplantation of healthy-donor derived blood stem cells into people with a T-cell lymphoma type of blood cancer?

1 outlet · first reported by Cochrane Evidence 16d ago

Coverage, in order

16d ago

Cochrane Evidence UK indie study
What are the benefits and risks of a transplantation of healthy-donor derived blood stem cells into people with a T-cell lymphoma type of blood cancer?
Key messages As a first treatment for someone with a rare white blood cell cancer (MTCL), giving someone stem cells from another person (alloSCT) rather than their own stem cells (autoSCT) may make little or no difference to their chance of treatment success or survival. As an extra treatment for…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.